| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 136/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
The product is a fluoroquinolone antibacterials, with broad-spectrum antibacterial effect, especially for aerobic gram-negative bacilli high antibacterial activity, on the following in vitro bacterial with good antibacterial effect:Enterobacteriaceae most bacteria, including citric acid bacterium, Enterobacter cloacae, Enterobacter aerogenes,enterobacter, Escherichia coli rare bacterium, Cray Borrelia bacteria of the genus, proteus, Salmonella, Shigella,yersinia genus Vibrio, etc.. Norfloxacin lactate
Function of Pharmaceutical Raw Material API Antibacterial Drugs CAS NO 70458-96-7 Norfloxacin
It can be used for urinary tract infection, gonorrhea, prostatitis, enteral infection, typhus and Salmonella infection, all of which are caused by the sensitive organism.
Function
The product is a fluoroquinolone antibacterials, with broad-spectrum antibacterial effect, especially for aerobic gram-negative bacilli high antibacterial activity, on the following in vitro bacterial with good antibacterial effect:Enterobacteriaceae most bacteria, including citric acid bacterium, Enterobacter cloacae, Enterobacter aerogenes,enterobacter, Escherichia coli rare bacterium, Cray Borrelia bacteria of the genus, proteus, Salmonella, Shigella,yersinia genus Vibrio, etc.. Norfloxacin lactate
Application
Noxifloxacin is a nearly white crystalline powder chemical with a molecular formula of C21H24FN3O4, a molecular weight of 401.4314, a melting point of 193-195°C, insoluble in water, slightly soluble in ethanol, and almost insoluble in acetone. Moxifloxacin belongs to the class of quinolones and is mainly used clinically for the treatment of adults (≥18 years old) suffering from upper respiratory tract and lower respiratory tract infections such as acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, and skin and Soft tissue infections.
| Batch No. | HF161118 | Quantity | 1110kgs |
| Mfg. Date | Nov.18, 2016 | Package | As required |
| Rep. Date | Nov.25, 2016 | Exp. Date | Nov.17, 2018 |
| Items | Standards | Results | |
| Appearance | White or off-white amorphous,odorless,hygroscopic powder | Complies | |
| Identification | By IR | Complies | |
| By UV | Complies | ||
| By TLC | Complies | ||
| By Masculine reaction | Complies | ||
| Specific Rotation | -0.5°~+0.5° | 0° | |
| Water Content | ≤3.00% | 1.50% | |
| Heavy Metal | ≤10ppm | Complies | |
| Free Aromatic Amine | ≤0.05% | 0.01% | |
| Free Iodine | Complies with standard | Complies | |
| Free Iodide | ≤0.001% | ND | |
| Ionic Compounds | ≤0.01% | ND | |
| Residual Solvent | Isopropyl alcohol ≤50ppm | 1ppm | |
| Methanol ≤50ppm | 1ppm | ||
| Methoxyethanol ≤20ppm | 2ppm | ||
| N-Butanol ≤50ppm | 1ppm | ||
| 3-Chloro-1,2-propanedio ≤25ppm | ND | ||
| Color Of Solution | 400nm:≤0.180 | 0.137 | |
| 420nm≤0.030 | 0.006 | ||
| 450nm≤0.015 | 0.000 | ||
| Related Substance | Impurity A: ≤0.30% | 0.14% | |
| O-alkylated compounds:≤0.50% | 0.48% | ||
| Any individual impurity:≤0.10% | 0.04% | ||
| The total impurities:≤0.30% | 0.13% | ||
| Assay (HPLC,basis on drying) |
98.5%~102.0% | 99.10% | |
| Reference Standard | USP36 and TCS09-602-09 Standard | ||
| Conclusion | The product complied to USP36 and TCS09-602-09 Standard. | ||
| Storage | The product is hygroscopic and odorless,preserve in tight,sealed and light-resistant containers in a cool place | ||
){kind=link}